Literature DB >> 11178859

Internal derangement of the temporomandibular joint treated by discectomy and hemi-arthroplasty with a Christensen fossa-eminence prosthesis.

N M McLeod1, N R Saeed, R Hensher.   

Abstract

Patients with internal derangement of the temporomandibular joint (TMJ) who have failed to respond to conservative treatment can be treated by discectomy and insertion of a Christensen fossa-eminence prosthesis, provided there is no clinical or radiological evidence of condylar disease (such as avascular necrosis). A total of 42 patients who had significant symptoms related to internal derangement of the TMJ, despite nonsurgical treatment, had discectomies and fossa-eminence prostheses inserted. Preoperative and postoperative measurements were recorded for Gape, Pain and restriction of feeding. All but one of the 34 patients showed improvements in their symptoms postoperatively. There were no serious postoperative complications.

Entities:  

Mesh:

Year:  2001        PMID: 11178859     DOI: 10.1054/bjom.2000.0562

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  4 in total

1.  Factors to consider in joint prosthesis systems.

Authors:  Larry M Wolford
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-07

2.  Considerations for translation of tissue engineered fibrocartilage from bench to bedside.

Authors:  Ryan P Donahue; Erik A Gonzalez-Leon; Jerry C Hu; Kyriacos Athanasiou
Journal:  J Biomech Eng       Date:  2018-12-05       Impact factor: 2.097

3.  Outcome of amniotic membrane as an interpositional arthroplasty of TMJ ankylosis.

Authors:  Mahmuda Akhter; Niaz Ahmed; Md Raihan-Ul Arefin; Mahbub-Us Sobhan; Motiur Rahman Molla; Mahammad Kamal
Journal:  Oral Maxillofac Surg       Date:  2015-09-28

Review 4.  Temporomandibular disorders: a review of etiology, clinical management, and tissue engineering strategies.

Authors:  Meghan K Murphy; Regina F MacBarb; Mark E Wong; Kyriacos A Athanasiou
Journal:  Int J Oral Maxillofac Implants       Date:  2013 Nov-Dec       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.